A MIXED TREATMENT COMPARISON OF EFFICACY AND CARDIOMETABOLIC SAFETY OF BELATACEPT, CYCLOSPORINE AND TACROLIMUS FOR IMMUNOSUPPRESSION THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS: 762